
Improve patient outcomes with AI-powered pathology for biopharma and diagnostic labs.
PathAI is an AI-powered pathology platform that improves patient outcomes by providing advanced digital pathology solutions for biopharma and anatomic pathology labs. It features the FDA-cleared AISight® Dx platform for image management and AI algorithms for biomarker discovery and drug development. Best for large laboratories and pharmaceutical companies. Pricing is enterprise-based.
PathAI provides AI-powered pathology solutions for biopharma and anatomic pathology laboratories, aiming to improve patient outcomes. It offers the AISight® Digital Pathology Platform for image and case management, alongside a suite of AI algorithms for biomarker discovery, drug development, and workflow optimization. The platform is FDA-cleared for primary diagnosis, serving leading research centers and pharmaceutical companies.
PathAI's AISight® Dx Digital Pathology Platform is FDA 510(k) cleared for primary diagnosis, making it a reliable AI-powered tool for clinical use in anatomic pathology labs.
Best For
Company Size
Complexity
Target Team Size
Target Skill Level
Fair
Based on 6 verified signals
Enterprise-level, including pilot integration and collaboration.